{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:55:35Z","timestamp":1773388535384,"version":"3.50.1"},"reference-count":171,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2020,6,17]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Burkholderia cepacia<\/jats:named-content>\n            (formerly\n            <jats:named-content content-type=\"genus-species\">Pseudomonas cepacia<\/jats:named-content>\n            ) was once thought to be a single bacterial species but has expanded to the\n            <jats:named-content content-type=\"genus-species\">Burkholderia cepacia<\/jats:named-content>\n            complex (Bcc), comprising 24 closely related opportunistic pathogenic species. These bacteria have a widespread environmental distribution, an extraordinary metabolic versatility, a complex genome with three chromosomes, and a high capacity for rapid mutation and adaptation. Additionally, they present an inherent resistance to antibiotics and antiseptics, as well as the abilities to survive under nutrient-limited conditions and to metabolize the organic matter present in oligotrophic aquatic environments, even using certain antimicrobials as carbon sources.\n          <\/jats:p>","DOI":"10.1128\/cmr.00139-19","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T18:01:07Z","timestamp":1586887267000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":152,"title":["<i>Burkholderia cepacia<\/i>\n            Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products"],"prefix":"10.1128","volume":"33","author":[{"given":"Mariana","family":"Tavares","sequence":"first","affiliation":[{"name":"iBB\u2013Institute for Bioengineering and Biosciences, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"},{"name":"Department of Bioengineering, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Mariya","family":"Kozak","sequence":"additional","affiliation":[{"name":"iBB\u2013Institute for Bioengineering and Biosciences, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"},{"name":"Department of Bioengineering, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Alexandra","family":"Balola","sequence":"additional","affiliation":[{"name":"iBB\u2013Institute for Bioengineering and Biosciences, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"},{"name":"Department of Bioengineering, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Isabel","family":"S\u00e1-Correia","sequence":"additional","affiliation":[{"name":"iBB\u2013Institute for Bioengineering and Biosciences, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"},{"name":"Department of Bioengineering, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-016-7520-x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8221.1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1085"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2007.03706.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2008.00113.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2006.04.006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1996.tb08517.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.phyto.39.1.225"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2011.00012"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.6.2926-2928.2005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-344OC"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200101000-00004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/598937"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-010-0017-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.148405"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix559"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/607575"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-014-1442-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1078\/072320203770865909"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1605(00)00255-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-011-0267-2"},{"key":"e_1_3_2_23_2","first-page":"42","article-title":"A review of reported recalls involving microbiological control 2004\u20132011 with emphasis on FDA considerations of \u201cobjectionable organisms","volume":"15","author":"Sutton S","year":"2012","unstructured":"Sutton S, Jimenez L. 2012. A review of reported recalls involving microbiological control 2004\u20132011 with emphasis on FDA considerations of \u201cobjectionable organisms.\u201d Am Pharm Rev 15:42\u201357.","journal-title":"Am Pharm Rev"},{"key":"e_1_3_2_24_2","first-page":"383","article-title":"Microbial diversity in pharmaceutical product recalls and environments","volume":"61","author":"Jimenez L","year":"2007","unstructured":"Jimenez L. 2007. Microbial diversity in pharmaceutical product recalls and environments. PDA J Pharm Sci Technol 61:383\u2013399.","journal-title":"PDA J Pharm Sci Technol"},{"key":"e_1_3_2_25_2","first-page":"205","article-title":"Burkholderia cepacia: a problem that does not go away!","volume":"2","author":"Jimenez L","year":"2015","unstructured":"Jimenez L, Kulko E, Barron E, Flannery T. 2015. Burkholderia cepacia: a problem that does not go away! EC Microbiol 2:205\u2013210.","journal-title":"EC Microbiol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjbas.2016.08.005"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1201\/9780203026267"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.147"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.748035"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp253"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn540"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.07.003"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00138-07"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01716-16"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2018.05.019"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/jam.12320"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-6-66"},{"key":"e_1_3_2_38_2","unstructured":"Cundell T. 2019. Excluding Burkholderia cepacia complex from aqueous non-sterile drug products. Am Pharm Rev https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/358427-Excluding-i-Burkholderia-cepacia-i-complex-from-Aqueous-Non-Sterile-Drug-Products\/. Accessed 25 May 2019."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2011.00793"},{"key":"e_1_3_2_40_2","volume-title":"Technical report no. 67. Exclusion of objectionable microorganisms from nonsterile pharmaceuticals, medical devices, and cosmetics","author":"Parenteral Drug Association, Exclusion of objectionable microorganisms from Nonsterile Pharmaceuticals, Medical Devices, and Cosmetics Technical Report Team","year":"2014","unstructured":"Parenteral Drug Association, Exclusion of objectionable microorganisms from Nonsterile Pharmaceuticals, Medical Devices, and Cosmetics Technical Report Team. 2014. Technical report no. 67. Exclusion of objectionable microorganisms from nonsterile pharmaceuticals, medical devices, and cosmetics. Parenteral Drug Association, Bethesda, MD. https:\/\/store.pda.org\/TableOfContents\/TR67_TOC.pdf."},{"key":"e_1_3_2_41_2","first-page":"36","article-title":"What is an \u201cobjectionable organism","volume":"15","author":"Sutton S","year":"2012","unstructured":"Sutton S. 2012. What is an \u201cobjectionable organism.\u201d Am Pharm Rev 15:36\u201348.","journal-title":"Am Pharm Rev"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.000251"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.002293"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02046"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx076"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00207"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-121"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0801-9"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2016.02.014"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08836-0"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.68.8.3750-3758.2002"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsle.2005.06.026"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47788-0"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01366-10"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028831"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201000457"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00068-09"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000094"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000177285.44374.dc"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02489-08"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.06.010"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.30802\/AALAS-JAALAS-18-000106"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky423"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-17"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.25.3.476-483.1973"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2015.8"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-1-11"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2011.06.004"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198384"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.15406\/ijvv.2016.03.00064"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1086\/660876"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.41.9.4113-4120.2003"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6778"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.182010"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.42.1800540"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.07.016"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.5897\/AJMR2015.7661"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00234-07"},{"key":"e_1_3_2_79_2","volume-title":"Recalls, market withdrawals, & safety alerts","author":"United States Food and Drug Administration","year":"2019","unstructured":"United States Food and Drug Administration. 2019. Recalls, market withdrawals, & safety alerts. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts. Accessed 25 May 2019."},{"key":"e_1_3_2_80_2","volume-title":"FDA updates on multistate outbreak of Burkholderia cepacia infections","author":"United States Food and Drug Administration","year":"2017","unstructured":"United States Food and Drug Administration. 2017. FDA updates on multistate outbreak of Burkholderia cepacia infections. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-multistate-outbreak-burkholderia-cepacia-infections. Accessed 25 May 2019."},{"key":"e_1_3_2_81_2","volume-title":"FDA updates on 2017 Burkholderia cepacia contamination","author":"United States Food and Drug Administration","year":"2017","unstructured":"United States Food and Drug Administration. 2017. FDA updates on 2017 Burkholderia cepacia contamination. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-2017-burkholderia-cepacia-contamination. Accessed 25 May 2019."},{"key":"e_1_3_2_82_2","volume-title":"FDA alerts consumers, pet owners not to use products manufactured by King Bio, including Dr. King\u2019s label, homeopathic drug and pet products","author":"United States Food and Drug Administration","year":"2018","unstructured":"United States Food and Drug Administration. 2018. FDA alerts consumers, pet owners not to use products manufactured by King Bio, including Dr. King\u2019s label, homeopathic drug and pet products. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-alerts-consumers-pet-owners-not-use-products-manufactured-king-bio-including-dr-kings-label. Accessed 25 May 2019."},{"key":"e_1_3_2_83_2","volume-title":"USP <797> Pharmaceutical compounding\u2013sterile preparations","author":"United States Pharmacopeial Convention","year":"2008","unstructured":"United States Pharmacopeial Convention. 2008. USP <797> Pharmaceutical compounding\u2013sterile preparations. https:\/\/www.sefh.es\/fichadjuntos\/USP797GC.pdf. Accessed 24 September 2019."},{"key":"e_1_3_2_84_2","volume-title":"USP <795> Pharmaceutical compounding\u2013nonsterile preparations","author":"United States Pharmacopeial Convention","year":"2014","unstructured":"United States Pharmacopeial Convention. 2014. USP <795> Pharmaceutical compounding\u2013nonsterile preparations. https:\/\/www.uspnf.com\/sites\/default\/files\/usp_pdf\/EN\/USPNF\/revisions\/gc795.pdf. Accessed 24 September 2019."},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2014.11.015"},{"key":"e_1_3_2_86_2","volume-title":"USP <61> Microbiological examination of non-sterile products: microbial enumeration tests","author":"United States Pharmacopeial Convention","year":"2008","unstructured":"United States Pharmacopeial Convention. 2008. USP <61> Microbiological examination of non-sterile products: microbial enumeration tests. U.S. Pharmacopeia, Rockville, MD. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-method\/q05b_pf_ira_34_6_2008.pdf. Accessed 6 April 2020."},{"key":"e_1_3_2_87_2","volume-title":"USP <62> Microbiological examination of non-sterile products: tests for specified microorganisms","author":"United States Pharmacopeial Convention","year":"2008","unstructured":"United States Pharmacopeial Convention. 2008. USP <62> Microbiological examination of non-sterile products: tests for specified microorganisms. U.S. Pharmacopeia, Rockville, MD. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-method\/q05a_pf_ira_34_6_2008.pdf. Accessed 6 April 2020."},{"key":"e_1_3_2_88_2","first-page":"464","article-title":"Burkholderia cepacia growth in preserved pharmaceutical antihistaminic oral suspension","volume":"8","author":"Eissa ME","year":"2016","unstructured":"Eissa ME. 2016. Burkholderia cepacia growth in preserved pharmaceutical antihistaminic oral suspension. Int J Pharm Pharm Sci 8:464\u2013466.","journal-title":"Int J Pharm Pharm Sci"},{"key":"e_1_3_2_89_2","volume-title":"FDA advises drug manufacturers that Burkholderia cepacia complex poses a contamination risk in non-sterile, water-based drug products","author":"United States Food and Drug Administration","year":"2017","unstructured":"United States Food and Drug Administration. 2017. FDA advises drug manufacturers that Burkholderia cepacia complex poses a contamination risk in non-sterile, water-based drug products. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile. Accessed 25 May 2019."},{"key":"e_1_3_2_90_2","volume-title":"Water for pharmaceutical use","author":"United States Food and Drug Administration","year":"2014","unstructured":"United States Food and Drug Administration. 2014. Water for pharmaceutical use. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/inspection-technical-guides\/water-pharmacuetical-use. Accessed 24 September 2019."},{"key":"e_1_3_2_91_2","volume-title":"USP <1112> Application of water activity determination to nonsterile pharmaceutical products","author":"United States Pharmacopeial Convention","year":"2012","unstructured":"United States Pharmacopeial Convention. 2012. USP <1112> Application of water activity determination to nonsterile pharmaceutical products. U.S. Pharmacopeia, Rockville, MD. http:\/\/www.triphasepharmasolutions.com\/Private\/USP%201112%20APPLICATION%20OF%20WATER%20ACTIVITY%20DETERMINATION%20TO%20NONSTERILE%20PHARMACEUTICAL%20PRODUCTS.pdf. Accessed 24 September 2019."},{"key":"e_1_3_2_92_2","first-page":"307","article-title":"Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems","volume":"1","author":"Maillard JY","year":"2005","unstructured":"Maillard JY. 2005. Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems. Ther Clin Risk Manag 1:307\u2013320.","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2008.08.015"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1706.06034"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-015-1605-x"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.13.8.899"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01571-10"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00140-13"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1207025110"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.112408.134306"},{"key":"e_1_3_2_102_2","doi-asserted-by":"crossref","unstructured":"Santos FG Pitts B Stewart PS Mantovani HC. 2018. Nisin penetrates Staphylococcus aureus biofilms but shows differences in killing effects against sessile and planktonic cells. bioRxiv doi:10.1101\/303636.","DOI":"10.1101\/303636"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-90"},{"key":"e_1_3_2_104_2","volume-title":"Committee for Human Medicinal Products (CHMP). Benzalkonium chloride used as an excipient","author":"European Medicines Agency (EMA)","year":"2017","unstructured":"European Medicines Agency (EMA). 2017. Committee for Human Medicinal Products (CHMP). Benzalkonium chloride used as an excipient. European Medicines Agency, Amsterdam, Netherlands. https:\/\/www.ema.europa.eu\/en\/documents\/report\/benzalkonium-chloride-used-excipient-report-published-support-questions-answers-benzalkonium_en.pdf. Accessed 25 May 2019."},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2003.tb03440.x"},{"key":"e_1_3_2_106_2","first-page":"23","article-title":"The disinfectant effects of benzalkonium chloride on some important foodborne pathogens","volume":"12","author":"Fazlara A","year":"2012","unstructured":"Fazlara A, Ekhtelat M. 2012. The disinfectant effects of benzalkonium chloride on some important foodborne pathogens. Am-Eurasian J Agric Environ Sci 12:23\u201329.","journal-title":"Am-Eurasian J Agric Environ Sci"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2014.11.010"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2411.171929"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2017.09.012"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2018.00095"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.37.3.505-510.1979"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03364-14"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2012.03277.x"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.107"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.4137\/MBI.S25800"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1384"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-0901-y"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00031-15"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52604-9"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.4.1004-1007.1999"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.41.9.4009-4015.2003"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200808-097GO"},{"key":"e_1_3_2_123_2","volume-title":"Microbial identification strategy for pharmaceutical microbiology","author":"Sandle T","year":"2017","unstructured":"Sandle T. 2017. Microbial identification strategy for pharmaceutical microbiology. Institute of Validation Technology, Burlington, MA. http:\/\/www.ivtnetwork.com\/article\/microbial-identification-strategy-pharmaceutical-microbiology. Accessed 20 May 2019."},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-019-0306-0"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.3.1073-1078.2001"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-56"},{"key":"e_1_3_2_127_2","first-page":"12","article-title":"Nucleic acid amplification-based rapid microbiological methods: are these technologies ready for deployment in the pharmaceutical industry?","volume":"12","author":"Denoya CD","year":"2009","unstructured":"Denoya CD. 2009. Nucleic acid amplification-based rapid microbiological methods: are these technologies ready for deployment in the pharmaceutical industry? Am Pharm Rev 12:12.","journal-title":"Am Pharm Rev"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-4581.1998.tb00185.x"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7012(00)00164-0"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3165-3173.2000"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01460-07"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.019844-0"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46457-0"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00770-09"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-019-2614-0"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-7012(01)00367-0"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2015.006049"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2017.007971"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.10.017"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1186\/gm485"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00672"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjm.2016.06.011"},{"key":"e_1_3_2_143_2","first-page":"299","article-title":"Burkholderia cepacia complex outbreaks among non-cystic fibrosis patients in the intensive care units: a review of adult and pediatric literature","volume":"26","author":"Abdallah M","year":"2018","unstructured":"Abdallah M, Abdallah HA, Memish ZA. 2018. Burkholderia cepacia complex outbreaks among non-cystic fibrosis patients in the intensive care units: a review of adult and pediatric literature. Infez Med 26:299\u2013307.","journal-title":"Infez Med"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304129"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.13768"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2015.06.009"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2016.07.008"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-015-1855-7"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.11"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.265"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.08.011"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.49.17-00213"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.01.024"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy910"},{"key":"e_1_3_2_155_2","volume-title":"The Burkholderia cepacia complex. Suggestions for prevention and infection control","author":"The UK Cystic Fibrosis Trust Infection Control Group","year":"2004","unstructured":"The UK Cystic Fibrosis Trust Infection Control Group. 2004. The Burkholderia cepacia complex. Suggestions for prevention and infection control. Cystic Fibrosis Trust, London, United Kingdom. https:\/\/www.cysticfibrosis.org.uk\/the-work-we-do\/resources-for-cf-professionals\/consensus-documents. Accessed 28 December 2018."},{"key":"e_1_3_2_156_2","first-page":"566","article-title":"An investigation on surgical-site infection among post cesarean section patients with Burkholderia cepacia contaminated ultrasonic couplant","volume":"35","author":"Wang M","year":"2014","unstructured":"Wang M, Zhang L, Xia S, Wu H, Zhang R, Fan M, Wang T. 2014. An investigation on surgical-site infection among post cesarean section patients with Burkholderia cepacia contaminated ultrasonic couplant. Zhonghua Liu Xing Bing Xue Za Zhi 35:566\u2013568.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.12.046"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2015.02.013"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005081"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.06.025"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_16_258"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2017.09.010"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.11.018"},{"key":"e_1_3_2_164_2","first-page":"10","article-title":"Nosocomial Burkholderia cepacia infection in a tertiary hospital; five-year surveillance: a retrospective cross-sectional study","volume":"6","author":"Nazik S","year":"2018","unstructured":"Nazik S, Topal B, \u015eahin AR, Ate\u015f S. 2018. Nosocomial Burkholderia cepacia infection in a tertiary hospital; five-year surveillance: a retrospective cross-sectional study. Urology 6:10\u201313.","journal-title":"Urology"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.10.008"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.65634-0"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2508(03)00026-3"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.02888-0"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2000.tb02500.x"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-45-2-274"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.syapm.2013.06.003"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-51-4-1481"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00139-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00139-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T12:58:28Z","timestamp":1645621108000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00139-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":171,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6,17]]}},"alternative-id":["10.1128\/CMR.00139-19"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00139-19","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"2020-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00139-19"}}